NCT03128255

Brief Summary

Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 25, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

April 26, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

May 4, 2017

Status Verified

April 1, 2017

Enrollment Period

2 months

First QC Date

April 20, 2017

Last Update Submit

May 3, 2017

Conditions

Keywords

FusionHybrid ImagingMappingIodineUltrasound

Outcome Measures

Primary Outcomes (1)

  • Metabolic-sonographic nodule allocation

    The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale.

    1 year

Study Arms (2)

Regular Thyroid Work-up

Nuclear Medicine physicians evaluate up to 34 cases of patients who have received regular thyroid diagnostics. Data and images of patient characteristics, laboratory results, ultrasonography loops and planar 99mTcO4 scintigraphy are provided and the physicians are asked to assign the function (hypo-, iso-, hyperfunctional) to predefined thyroid nodules visible on ultrasonography.

Regular Thyroid Work-up and I-124 PET/US

Nuclear Medicine physicians evaluate up to 34 cases of patients who have received regular thyroid diagnostics and additional I-124 PET/CT, followed by I-124 PET/US (administration of I-124 was not subject of this study). Data and images of patient characteristics, laboratory results, ultrasonography loops, planar 99mTcO4 scintigraphy as well as I-124 PET/US loops are provided and the physicians are asked to assign the function (hypo-, iso-, hyperfunctional) to predefined thyroid nodules visible on ultrasonography.

Other: Assessment of already preacquired I-124 PET/US

Interventions

Assessment of preacquired I-124 PET/US by review of anonymous digital case files

Regular Thyroid Work-up and I-124 PET/US

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data of patients with unclear findings on regular thyroid work-up who had received additional I-124-PET/US in our institution.

You may qualify if:

  • patients with thyroidal nodules,
  • euthyroidism
  • Uptake \>0,5% on Tc-99m-pertechnetate- scintigraphy

You may not qualify if:

  • thyroid medications in the last 6 months
  • Iodine exposition in the last 6 months
  • thyroid surgery or radioiodine therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Jena

Jena, Thuringia, 07747, Germany

RECRUITING

MeSH Terms

Conditions

Thyroid NoduleThyroid DiseasesGoiter

Condition Hierarchy (Ancestors)

Thyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2017

First Posted

April 25, 2017

Study Start

April 26, 2017

Primary Completion

July 1, 2017

Study Completion

April 1, 2018

Last Updated

May 4, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations